Wilson’s disease: Transplantation when all else has failed
Open Access
- 1 July 1988
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 8 (4) , 975-976
- https://doi.org/10.1002/hep.1840080447
Abstract
Experience with liver transplantation for patients with Wilson’s disease who have major neurological impairment is limited, and this report describes the results obtained in two such patients. The first was a 30-year-old man with a 14-month history of hepatic and neurological impairment. In spite of treatment with d-penicillamine, he developed increasing dysarthria, dysphagia, akinesia and rigidity of all four limbs, and required continuous nursing care. Following transplantation, liver function was almost normal from four weeks onwards, but recovery of neurological function was much slower and was not seen until two to three months after surgery. By four months he was sufficiently mobile to be discharged, and when he returned for assessment at eight months, no abnormal neurological signs were detectable. The second patient was a 27-year-old woman with worsening liver dysfunction for eight years; one year previously she had developed dysarthria, akinesia, a fine tremor and moderate rigidity of all limbs as well as marked psychological impairment. There was no improvement on treatment with d-penicillamine or trientine, but as liver function returned to normal two months after liver grafting, her neurological and psychological function began to improve so that by three months she could be discharged.Keywords
This publication has 4 references indexed in Scilit:
- The Use of Trientine in Preventing the Effects of Interrupting Penicillamine Therapy in Wilson's DiseaseNew England Journal of Medicine, 1987
- PENICILLAMINE MAY DETOXIFY COPPER IN WILSON'S DISEASEThe Lancet, 1987
- Wilson’s Disease: Indications for Liver TransplantsHepatology, 1984
- LIVER TRANSPLANTATION FOR WILSON'S DISEASEThe Lancet, 1975